Olga Tarasiuk


+39 02 6448 8110
Olga Tarasiuk

Curriculum Vitae


Tarasiuk Olga has been born in Ukraine 22 April 1989. She received bachelor and master education in Biomedical Science at University of Hasselt, Belgium. In 2018 she received a PhD degree in Biotechnology and Medical Science at University of Eastern Piedmont, Italy. During her PhD she engineered recombinant monoclonal humanized antibodies against a target protein involved in cancer progression that can be used as a potential drug for cancer immunotherapy. Nowadays she is working on a project that study interplay between Mesenchymal Stem Cells and peripheral nervous system. Moreover, she is involved in the project that study kinase phosphorylation biological activity as target in cancer drug treatment.




  • Recombinant antibodies immunotherapy
  • Drug development for oncology
  • Mesenchymal Stem Cells therapy



Dal Ferro M, Rizzo S, Rizzo E, Marano F, Luisi I, Tarasiuk O, Sblattero D. “Phage display technology for human monoclonal antibodies” Michael Steinitz (ed.), Human Monoclonal Antibodies: Methods and Protocols, Methods in Molecular Biology, vol. 1904, Springer 2019

Antony F, Deantonio C, Cotella D, Soluri MF, Tarasiuk O, Mezzanzanica D, Adorni F, Piazza S, Ciani Y, Santoro C, Macor P, Sblattero D. (2019) “High-
throughput assessment of the antibody profile in ovarian cancer ascitic fluids”, OncoImmunology, 8:9

Frank A*, Tarasiuk O*, Cotella D, Soluri MF, Corazzari M, Santoro C, Sblattero D. “Protein Disulfide Isomerase in ovarian cancer: a novel tumor-associated antigen and a potential target for cancer therapy” (under preparation) **contributed equally

Find out more on SCOPUS